Concepedia

Jennifer Nicki

JN

Statistics

Publications

6

Citations

361

H-Index

6

Active since

2013

Affiliations

Pfizer (United States)(Current)

Jennifer Nicki is an author at Pfizer (United States) specializing in infectious diseases, antiviral therapy, and molecular virology.

ORCID

Publications per year

2013–2025

6

Publications

6

Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants

S.E. Greasley, Stephen Noell, Olga Plotnikova et al. · Journal of Biological Chemistry · 2022 · 174 citations · Full text

, , +16

Transgenic Parasites Stably Expressing Full-Length Plasmodium falciparum Circumsporozoite Protein as a Model for Vaccine Down-Selection in Mice Using Sterile Protection as an Endpoint

Michael D. Porter, Jennifer Nicki, Margot DeBot et al. · Clinical and Vaccine Immunology · 2013 · 53 citations · Full text

, , +17

A scalable method for biochemical purification of Salmonella flagellin

Raphael Simon, Brittany Curtis, Vehid Deumic et al. · Protein Expression and Purification · 2014 · 47 citations · Full text

, , +16

In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance

Yuao Zhu, Irina Yurgelonis, Stephen Noell et al. · Science Advances · 2024 · 45 citations · Full text

, , +16

Structural basis for Nirmatrelvir in vitro efficacy against SARS-CoV-2 variants

S.E. Greasley, Stephen Noell, Olga Plotnikova et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2022 · 27 citations · Full text

, , +15

1–5 of 6